Rett Syndrome Clinical Trial
Official title:
The Findings of Resting-state Functional Magnetic Resonance Imaging , Susceptibility Weighted Imaging and Diffusion Spectrum Imaging in Rett Syndrome
Introduction: Rett Syndrome is a neurodevelopmental disease that primarily affects girls.
Clinically, patients are normal before six months to one and half years old, and then
develop progressive severe problems with communication, learning, co-ordination and
neurodevelopment, with loss of motor skills around the age of two. At the same time,
stereotyped hand movement typically appears. However, some of them will improve the
abilities in speech and eye gaze, and the repetitive hand movements may decrease after few
years.
Background / hypothesis:Preliminary evidence suggests that there are many differences in
brain structure between Rett syndrome and normal people including cerebral volume reduction
in both white matter and gray matter, cerebral blood flow in the frontal area, and density
of receptors in basal ganglia. In MR imaging studies, decreases in parietal lobe gray matter
were found, and several reductions in cortical white matter were observed by DTI. However,
the visual related pathway- posterior corona radiata in Rett syndrome girls was normal to be
increased in FA values. The similar result was also discovered in the superior longitudinal
fasciculus, associated with speech, which equal to control subjects and patients with
preserved speech (phrases and sentences).Despite this, few studies mentioned comparison with
brain microstructure in the different stage, especially in adult patients. Therefore, our
prospective study will be planned to figure out the specific changing pattern of brain
structure in different stages of Rett syndrome. And the trajectory of microstructure in
brain is going to be in accordance with the functional improvement.
The investigators suppose that (1)there are different microstructural changes for patients
with/without preserved mobility, verbal ability and communication skill; (2)there are a few
specific brain microstructures changes in visual pathway; (3) there is a specific changing
pattern of brain microstructure in different aging of Rett syndrome. To acquire more
specific results, the investigators aim to apply conventional MRI, diffusion-spectrum
imaging, and some clinical assessment tools like Rett syndrome -related questionnaire, SSI,
PDMS-2 and six-minute walk test to investigate their correlation.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | September 2017 |
Est. primary completion date | September 2017 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 3 Years to 30 Years |
Eligibility |
Inclusion Criteria: - Diagnosis: Rett Syndrome Exclusion Criteria: 1. Psychiatric diagnoses 2. History of neurological impairment 3. Neuropsychiatric conditions 4. Clinical evidence of a genetic disorder |
Observational Model: Case Control, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
Taiwan | Department of Pediatrics, National Taiwan University Hospital | Taipei |
Lead Sponsor | Collaborator |
---|---|
National Taiwan University Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | DSI data | Diffusion spectrum imaging(DSI), a more specific method to detects the fiber crossing of white matter, quantified by GFA value to investigate the tract-specific abnormalities with the growth trajectories and their correlations with clinical features in patients with RTT.DSI scans were acquired using a Siemens Tim Trio 3T scanner at NTUH. Diffusion spectrum imaging data were obtained in 32 channel head coil with following parameters: TE = 2.98 ms, TR = 2000 ms, slice per slab=208, slice thickness = 1.0mm, FoV read = 256mm, voxel size=2.5x2.5x2.5mm. | 40 minutes | Yes |
Secondary | Peabody developmental motor scales (PDMS-2), | A motor development program will be applied to assess the gross motor and fine motor skills objectively. PDMS-2 consists of 6 subjects: reflexes, stationary, locomotion, object manipulation, grasping, and visual-motor integration and can be used in clinical assessment and training. | within the first 90 days after scanning | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04988867 -
An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
|
Phase 2/Phase 3 | |
Recruiting |
NCT00069550 -
Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome
|
Phase 3 | |
Enrolling by invitation |
NCT06139172 -
Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities
|
N/A | |
Not yet recruiting |
NCT04014985 -
Patients With RETT Syndrome
|
N/A | |
Not yet recruiting |
NCT04041713 -
A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome
|
Phase 2 | |
Completed |
NCT02705677 -
Biobanking of Rett Syndrome and Related Disorders
|
||
Terminated |
NCT02790034 -
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
|
Phase 2/Phase 3 | |
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Recruiting |
NCT05932589 -
Neurophysiologic Biomarkers in Rett Syndrome
|
||
Recruiting |
NCT04463316 -
GROWing Up With Rare GENEtic Syndromes
|
||
Completed |
NCT04776746 -
Open-Label Extension Study of Trofinetide for Rett Syndrome
|
Phase 3 | |
Completed |
NCT04181723 -
Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDERâ„¢)
|
Phase 3 | |
Enrolling by invitation |
NCT03836300 -
Parent and Infant Inter(X)Action Intervention (PIXI)
|
N/A | |
Completed |
NCT04514549 -
ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME
|
||
Terminated |
NCT02562820 -
An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome
|
Phase 1 | |
Completed |
NCT02738281 -
Natural History of Rett Syndrome & Related Disorders
|
||
Completed |
NCT05687214 -
Osteopathic Manipulative Treatment for Constipation in People With Rett Syndrome
|
N/A | |
Recruiting |
NCT06199700 -
Esketamine for the Treatment of Rett Syndrome
|
Early Phase 1 | |
Completed |
NCT03941444 -
ANAVEX2-73 Study in Patients With Rett Syndrome
|
Phase 3 | |
Recruiting |
NCT06346106 -
The Diagnostic Experience of Male Rett Syndrome
|